Regulation of allergenic products in the United States: the promise and problem of adjuvants in allergen immunotherapy.
Rabin
Ronald L
RL
FDA/CBER, Rockville, MD 20850, USA.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000592:standards; D000485:Allergens / Q000008:administration & dosage*; D003888:Desensitization, Immunologic / Q000592:standards; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000592:standards; D033161:Government Regulation; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000276:Adjuvants, Immunologic; D000485:Allergens; D015507:Drugs, Investigational